Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Typical lung carcinoids(TCs)are rare tumors with good,although heterogeneous,prognosis.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Briganti V
Authors: Briganti V, Berti V, Abenavoli E, Linguanti F, Ciaccio A,
Keywords: typical lung carcinoid, FDG PET, SSTR imaging, MTV, TLG,
Introduction: In PRRT for NET, feasibility of lesion uptake quantification in Lu-177-DOTATOC SPECT/CT for therapy monitoring remains unclear.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Galler M, Schatka I, Buch F, Bluemel S, Jann H,
Keywords: Lu-177-DOTATOC, PRRT, NET, dosimetry, SPECT/CT, Quantification,
Introduction: SSR PET/CT is used in workup of pts with PCC/ PGL. Correlation of tumour burden on PET & biomarkers 24 hr Urine Metanephrines (UMET), normetanephrine (UNMET), UMET:creatinine ratio (MET:Crea),UNMET:creatinine (UNMET:crea) & Chromogranin A (CGA) has not been done.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Steyn R
Keywords: 68Ga DOTANOC PET CT, PGL, PCC,
Introduction: Increased tumour lesion absorbed dosimetry (TLAD) from peptide receptor radionuclide therapy (PRRT) is associated with neuroendocrine tumours (NET) response. Responses to PRRT might be impacted by NET grade, site of origin and use of concurrent chemotherapy.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Ladwa R, Pattison D, Smith J, Goodman S, Burge M,
Keywords: 68Ga-DOTATATE PET, Tumor Dosimetry, Response,
Introduction: Somatostatin receptors (SSTR) are known for an overexpression in neuroendocrine tumors (NET).
Conference: 8th Annual ENETSConcerence (2011)
Presenting Author:
Authors: Kaemmerer D, Peter L, Lupp A, Schulz S, Prasad V,
Keywords: clone UMB-4, molecular imaging, neuroendocrine tumor, somatostatin receptor, monoclonal antibodies,